Document Classification

Section Type: RESULTS

Text: An analysis for intention-to-treat (ITT) individuals showed that individuals with the treatment of theophylline experienced statistically fewer numbers [(0. 8 + / - 1. 2) times/year, (1. 7 + / - 2. 6) times/year, Z = -1. 674, P = 0. 047] and days of exacerbations [(4. 6 + / - 7. 9) d, (12. 5 + / - 22. 8) d, Z = -1. 699, P = 0. 045] in comparison to subjects receiving placebo, that patients receiving theophylline were less likely than the placebo group to experience moderate exacerbations [(0. 4 + / - 1. 0) times/year, (1. 0 + / - 1. 8) times/year, Z = -2. 136, P = 0. 017], and that more individuals satisfied with treatments in the theophylline group than the placebo group (n = 16, 3, Z = -2. 198, P = 0. 014), and that statistically greater improvement in pre-bronchodilators FEV (1) [(0. 006 + / - 0. 180) L, (-0. 053 + / - 0. 169) L, t = 1. 789, P = 0. 038] were found in the theophylline group in comparison to the placebo group.